FIELD: medicine, oncology. SUBSTANCE: medicinal lignin in the form of an aqueous-alkaline suspension is subjected for ultrasonic oscillation and oxidized with oxygen-containing gas. After reaction mass cooling and separation of solid phase the end product is isolated from an acidified solution. Ultrasonic oscillation is carried out at irradiation power 40.0 ± 0.5 Wt, oscillation frequency 22.0 ± 0.5 kHz for 20-25 min. Oxidation with oxygen-containing gas is carried out at 190-200 C, under pressure 2.0-2.5 MPa for 0.5-3.0 h. EFFECT: decreased tumor proliferation. 2 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTITUMOR AGENT "OLIPIFAT" AND METHOD OF ITS PREPARING | 1998 |
|
RU2141335C1 |
MEDICINAL PREPARATION POSSESSING ANTITUMOR ACTIVITY | 1988 |
|
RU2039560C1 |
ANTIANGIOGENIC MEDICINAL AGENT AND METHOD OF ITS PRODUCTION | 2009 |
|
RU2404783C1 |
USE OF THE COMPOUND 2-[3-(2-CHLOROETHYL)-3-NITROSOUREIDO]-1,3-PROPANEDIOL ORALLY FOR THE TREATMENT OF MELANOMA B16, EHRLICH TUMOR, SARCOMA 180, SARCOMA 37, LYMPHOSARCOMA LIO-1 AND CARCINOSARCOMA WALKER 256 EXPERIMENTALLY IN MICE AND RATS | 2020 |
|
RU2733643C1 |
METHOD OF PREPARING AGENT "OLIPIFAT" FOR TREATMENT OF PATIENTS WITH NONONCOLOGICAL PATHOLOGY IN BODY | 1998 |
|
RU2141334C1 |
METHOD TO TREAT MALIGNANT TUMORS IN ANIMALS | 1998 |
|
RU2180841C2 |
METHOD OF SYNTHESIS 2-[3-(2-CHLORETHYL)-3-NITROSOUREIDO]-1,3-PROPANE-DIOL OWNED WITH ANTITUMOR ACTIVITY | 2018 |
|
RU2678846C1 |
1,4-DIGLYCIDYL-3-ETHYL-1,2,4-TRIAZOLE-5-ONE SHOWING ANTITUMOR ACTIVITY | 1989 |
|
SU1651525A1 |
METHOD OF BIOLOGICALLY ACTIVE SUBSTANCE OLIPIFAT MANUFACTURE | 2008 |
|
RU2365377C1 |
DIHYDROCHLORIDE 1-(3-NITRO-4- METHOXYBENZENE)-2- [BIS-(2- CHLORETHYL) AMINOMETHYL]IMIDAZOLE POSSESSING ANTITUMOR ACTIVITY | 1981 |
|
SU976654A1 |
Authors
Dates
1998-01-20—Published
1996-08-22—Filed